123
Participants
Start Date
January 31, 2002
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
Nevirapine
Lamivudine
Zidovudine
Boehringer Ingelheim Investigational Site, Soweto
Boehringer Ingelheim Investigational Site, Tygerberg
Groote Schuur Hospital, Cape Town
Boehringer Ingelheim Investigational Site, Pretoria
Lead Sponsor
Boehringer Ingelheim
INDUSTRY